Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »
Reset 

Arbutus receives regulatory clearance to initiate Phase 1a/1b Clinical Trial of AB-729

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Arbutus Biopharma Corporation

BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML)

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  BeiGene, Ltd.

BioSig Technologies Issues June 2019 Shareholder Letter

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  BioSig Technologies, Inc.

Alimera’s ILUVIEN® Receives Positive NICE Recommendation for Non-Infectious Posterior Uveitis

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Alimera Sciences, Inc.

VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  VBI Vaccines Inc.

Albireo Announces Launch of “PFIC Voices”

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Albireo Pharma, Inc.

OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  OPKO Health, Inc.

Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Spero Therapeutics, Inc.

BioDelivery Sciences Named to the Russell 3000® Index

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  BioDelivery Sciences International, Inc.

Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  OptiNose US Inc.

BeyondSpring Set to Join FTSE Russell 3000® Index

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  BeyondSpring Pharmaceuticals Inc.

Predictive Technology Group Announces the Presentation of New Genetic Findings in Endometriosis at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Predictive Technology Group

Cybrexa Therapeutics Closes $13.4M in Series B1 Funding Round

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Cybrexa Therapeutics

Arvinas to Present at the BMO Prescriptions for Success Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Arvinas Inc.

Agritek Holdings, Inc. Announces Execution of Term Sheet for Cash Infusion of Up to $2.5 Million Dollars from Private Banking Partner and Equity Line for Expansion of Multi-State Cannabis Operations

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019

Progenics Pharmaceuticals to Initiate a Basket Trial by Year End to Support an Expanded Label for AZEDRA® (iobenguane I 131) in Multiple MIBG Avid Neuroendocrine Tumors

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Progenics Pharmaceuticals, Inc.

REPEAT: AgraFlora Organics Welcomes Collection of Industry Analysts, Institutional Investors and Media Personnel to June 25th Delta Greenhouse Tour; Broadcast To Be Made Available Online Via Corporate Website

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019

Wildflower Featured in CannabisNewsAudio Broadcast Discussing Profitability of Cannabis Sector

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019

Eloxx Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Eloxx Pharmaceuticals, Inc.

Turning Point Therapeutics Initiates Phase 2 Registrational Portion of TRIDENT-1 Clinical Study

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2019
Related companies:  Turning Point Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »
to the top ↑